Drug Information
硫酸沙丁胺醇吸入粉雾剂
吸入粉雾剂
200μg/吸（ 按C₁₃H₂₁NO₃计），200吸/支
化学药品
December 11, 2023
December 10, 2028
Company Information
Applicant Company
Orionintie 1, 02200 Espoo, Finland
Manufacturing Company
Orionintie 1, P.O.Box 65, Espoo,02200, Finland
NMPA Approval
Salbutamol Sulfate Inhalation Powder
H20130596
MedPath
Empowering clinical research with data-driven insights and AI-powered tools.
© 2025 MedPath, Inc. All rights reserved.